Literature DB >> 21237282

Role of tetraspanin CD151-α3/α6 integrin complex: Implication in angiogenesis CD151-integrin complex in angiogenesis.

Wei-Feng Liu1, Hou-Juan Zuo, Bo-lan Chai, Dan Peng, Yu-Jie Fei, Jing-Yang Lin, Xiao-Hui Yu, Dao-Wen Wang, Zheng-Xiang Liu.   

Abstract

Tetraspanin CD151 mainly associates with laminin-binding integrins and forms CD151-integrin complex. We previously reported that CD151 could be a potential target for angiogenesis, but the mechanisms involved are still unclear. This study investigated the role of CD151-integrin complex in angiogenesis and the signaling mechanisms involved. Here we showed that CD151 and CD151-AAA mutant were both well expressed at the protein level. CD151 gene transfer promoted angiogenesis and improved skin temperature of the lateral ischemic hindlimb, whereas CD151-AAA mutant abrogated the increase in capillary density and skin temperature. Further, CD151-AAA mutant failed to activate the FAK, ERK, PI3K/Akt/eNOS, and Rac1/Cdc42 signaling pathways. Moreover, CD151-AAA mutant was unavailable to promote bovine aortic endothelial cells (BAECs) proliferation and migration, in contrast to the effects of CD151. The results suggested that formation of CD151-integrin complex was likely to be a prerequisite for CD151-induced angiogenesis and signaling pathways.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21237282     DOI: 10.1016/j.biocel.2011.01.004

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  11 in total

Review 1.  Regulation of FAK Activity by Tetraspan Proteins: Potential Clinical Implications in Cancer.

Authors:  Yu Qin; Shabnam Mohandessi; Lynn Gordon; Madhuri Wadehra
Journal:  Crit Rev Oncog       Date:  2015

Review 2.  Tetraspanins in cell migration.

Authors:  Xupin Jiang; Jiaping Zhang; Yuesheng Huang
Journal:  Cell Adh Migr       Date:  2015-06-19       Impact factor: 3.405

Review 3.  Tetraspanin proteins promote multiple cancer stages.

Authors:  Martin E Hemler
Journal:  Nat Rev Cancer       Date:  2014-01       Impact factor: 60.716

4.  CD151 promotes proliferation and migration of PC3 cells via the formation of CD151-integrin α3/α6 complex.

Authors:  Wuxiao Yang; Pengcheng Li; Jingyang Lin; Houjuan Zuo; Ping Zuo; Yuanlin Zou; Zhengxiang Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-06-09

Review 5.  CD151 in cancer progression and metastasis: a complex scenario.

Authors:  Rafal Sadej; Alicja Grudowska; Lukasz Turczyk; Radzislaw Kordek; Hanna M Romanska
Journal:  Lab Invest       Date:  2013-11-18       Impact factor: 5.662

6.  Decellularized matrix from tumorigenic human mesenchymal stem cells promotes neovascularization with galectin-1 dependent endothelial interaction.

Authors:  Jorge S Burns; Malthe Kristiansen; Lars P Kristensen; Kenneth H Larsen; Maria O Nielsen; Helle Christiansen; Jan Nehlin; Jens S Andersen; Moustapha Kassem
Journal:  PLoS One       Date:  2011-07-11       Impact factor: 3.240

7.  The tetraspanin CD151-ARSA mutant inhibits angiogenesis via the YRSL sequence.

Authors:  Dan Peng; Houjuan Zuo; Zhengxiang Liu; Jin Qin; Yuanlin Zhou; Pengcheng Li; Daowen Wang; Hesong Zeng; Xin A Zhang
Journal:  Mol Med Rep       Date:  2012-12-24       Impact factor: 2.952

Review 8.  Migrasome and Tetraspanins in Vascular Homeostasis: Concept, Present, and Future.

Authors:  Yaxing Zhang; Jing Wang; Yungang Ding; Jiongshan Zhang; Yan Xu; Jingting Xu; Shuhui Zheng; Hongzhi Yang
Journal:  Front Cell Dev Biol       Date:  2020-06-16

9.  Regulation of Glioblastoma Tumor-Propagating Cells by the Integrin Partner Tetraspanin CD151.

Authors:  Jessica Tilghman; Paula Schiapparelli; Bachuchu Lal; Mingyao Ying; Alfredo Quinones-Hinojosa; Shuli Xia; John Laterra
Journal:  Neoplasia       Date:  2016-03       Impact factor: 5.715

10.  MiR-124 aggravates failing hearts by suppressing CD151-facilitated angiogenesis in heart.

Authors:  Yanru Zhao; Mengwen Yan; Chen Chen; Wei Gong; Zhongwei Yin; Huaping Li; Jiahui Fan; Xin A Zhang; Dao Wen Wang; Houjuan Zuo
Journal:  Oncotarget       Date:  2018-01-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.